Literature DB >> 21729767

Incorporation of historical data in the analysis of randomized therapeutic trials.

Charlotte Rietbergen1, Irene Klugkist, Kristel J M Janssen, Karel G M Moons, Herbert J A Hoijtink.   

Abstract

Historical studies provide a valuable source of information for the motivation and design of later trials. Bayesian techniques offer possibilities for the quantitative inclusion of prior knowledge within the analysis of current trial data. Combining information from previous studies into an informative prior distribution is, however, a delicate case. The power prior distribution is a tool to estimate the effect of an intervention in a current study sample, while accounting for the information provided by previous research. In this study we evaluate the use of the power prior distribution, illustrated with data from a large randomized clinical trial on the effect of ST-wave analysis in intrapartum fetal monitoring. We advocate the use of a power prior distribution with pre-specified fixed study weights based on differences in study characteristics. We propose obtaining a ranking of the historical studies via expert elicitation, based on relevance for the current study, and specify study weights accordingly.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21729767     DOI: 10.1016/j.cct.2011.06.002

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  10 in total

1.  Bayesian hierarchical modeling based on multisource exchangeability.

Authors:  Alexander M Kaizer; Joseph S Koopmeiners; Brian P Hobbs
Journal:  Biostatistics       Date:  2018-04-01       Impact factor: 5.899

2.  Bayesian immunological model development from the literature: example investigation of recent thymic emigrants.

Authors:  Tyson H Holmes; David B Lewis
Journal:  J Immunol Methods       Date:  2014-08-29       Impact factor: 2.303

3.  The power prior: theory and applications.

Authors:  Joseph G Ibrahim; Ming-Hui Chen; Yeongjin Gwon; Fang Chen
Journal:  Stat Med       Date:  2015-09-07       Impact factor: 2.373

4.  A gentle introduction to bayesian analysis: applications to developmental research.

Authors:  Rens van de Schoot; David Kaplan; Jaap Denissen; Jens B Asendorpf; Franz J Neyer; Marcel A G van Aken
Journal:  Child Dev       Date:  2013-10-09

5.  Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction.

Authors:  Charlotte Rietbergen; Gudrun Stefansdottir; Hubert G Leufkens; Mirjam J Knol; Marie L De Bruin; Irene Klugkist
Journal:  Front Med (Lausanne)       Date:  2018-02-22

6.  Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.

Authors:  Caroline Brard; Lisa V Hampson; Nathalie Gaspar; Marie-Cécile Le Deley; Gwénaël Le Teuff
Journal:  BMC Med Res Methodol       Date:  2019-04-24       Impact factor: 4.615

Review 7.  Prior Elicitation for Use in Clinical Trial Design and Analysis: A Literature Review.

Authors:  Danila Azzolina; Paola Berchialla; Dario Gregori; Ileana Baldi
Journal:  Int J Environ Res Public Health       Date:  2021-02-13       Impact factor: 3.390

8.  Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.

Authors:  Yu Wang; James Travis; Byron Gajewski
Journal:  BMC Med Res Methodol       Date:  2022-04-21       Impact factor: 4.612

9.  Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets.

Authors:  Alexander Kaizer; Emily Zabor; Lei Nie; Brian Hobbs
Journal:  PLoS One       Date:  2022-08-02       Impact factor: 3.752

10.  Incorporating measurement error in n = 1 psychological autoregressive modeling.

Authors:  Noémi K Schuurman; Jan H Houtveen; Ellen L Hamaker
Journal:  Front Psychol       Date:  2015-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.